Page last updated: 2024-09-04

5-phenyl-3-isoxazolecarboxylic acid and topiroxostat

5-phenyl-3-isoxazolecarboxylic acid has been researched along with topiroxostat in 1 studies

Compound Research Comparison

Studies
(5-phenyl-3-isoxazolecarboxylic acid)
Trials
(5-phenyl-3-isoxazolecarboxylic acid)
Recent Studies (post-2010)
(5-phenyl-3-isoxazolecarboxylic acid)
Studies
(topiroxostat)
Trials
(topiroxostat)
Recent Studies (post-2010) (topiroxostat)
1607801769

Protein Interaction Comparison

ProteinTaxonomy5-phenyl-3-isoxazolecarboxylic acid (IC50)topiroxostat (IC50)
Xanthine dehydrogenase/oxidaseBos taurus (cattle)0.8919
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)0.18

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Deng, L; Li, Z; Liu, Y; Nie, L; Xie, R; Xu, X1

Other Studies

1 other study(ies) available for 5-phenyl-3-isoxazolecarboxylic acid and topiroxostat

ArticleYear
Discovery of 2-phenylthiazole-4-carboxylic acid, a novel and potent scaffold as xanthine oxidase inhibitors.
    Bioorganic & medicinal chemistry letters, 2019, 02-15, Volume: 29, Issue:4

    Topics: Drug Discovery; Enzyme Inhibitors; Febuxostat; Thiazolidines; Xanthine Oxidase

2019